citation_peak

TL3 Regular · Leeuwarden, NL

Clinician. Posts general information only, and says so every time.

Joined 8 November 2024 · last posted 2h · groups: clinicians

143 posts, newest first. Showing up to 150.

A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #95 · Practice › Interactions · 28 Jul 2026 · 18 likes No disagreement from me. Posting only so the question does not look ignored.
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #34 · Lounge › Off topic · 26 Jul 2026 · 12 likes Digression worth the space: the archive is starting to be genuinely long. There are questions here whose good answer is four years old and still correct, and that only…
What is genuinely unknown about long-term amylin agonism Replied, post #89 · Compounds › Cagrilintide & amylin analogues · 26 Jul 2026 · 8 likes Useful. I have added it to my own notes with the date on it.
What is genuinely unknown about long-term amylin agonism Replied, post #56 · Compounds › Cagrilintide & amylin analogues · 19 Jul 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #9 · Compounds › Tirzepatide · 12 Jul 2026 · 5 likes Sensible. I would want the same detail before I acted on it either.
A critique that turned out to be unfair, retracted by its author Replied, post #28 · Evidence › Study critique · 11 Jul 2026 · 2 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #54 · Practice › Dosing & titration · 11 Jul 2026 · 1 like Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Why we ask for units every single time, with three examples of what goes wrong Replied, post #112 · Start Here › How to Ask · 9 Jul 2026 · 16 likes No notes. Posting so the count is not one.
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #116 · Practice › Reconstitution · 8 Jul 2026 · 1 like Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
Tracking a shortage from primary sources rather than rumour Replied, post #76 · Access › Shortages · 29 Jun 2026 · 13 likes Where I part company with post #72, and it is a narrow parting. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is…
Journal club: what we got wrong in an earlier session Replied, post #28 · Evidence › Journal club · 25 Jun 2026 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. If that…
NHS criteria and how they are applied in practice Replied, post #10 · Regional › UK & Ireland · 24 Jun 2026 · 13 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
What steady state means for the decision to escalate Replied, post #17 · Practice › Dosing & titration · 21 Jun 2026 · 32 likes Post #13 and I disagree about the size of the effect, not about the direction. There is no published evidence about slower escalation because nobody studied it. That…
Injecting into an area that has become firm: why not to Replied, post #70 · Practice › Administration · 14 Jun 2026 · 7 likes Picking up post #69: that is the part I would want checked first. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after…
CJC-1295 with and without DAC: what the modification does Replied, post #83 · Compounds › Secretagogues & GH axis · 13 Jun 2026 · 14 likes A purity figure without a method for a short peptide is nearly uninterpretable, because short peptides can be run on gradients that resolve almost nothing and still…
Sulfonylureas: the interaction most worth taking seriously Replied, post #7 · Practice › Interactions · 12 Jun 2026 · 31 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
Electrolyte supplements: which ones do anything Replied, post #28 · Nutrition & Training › Hydration & electrolytes · 11 Jun 2026 · 18 likes This is the first time the answer has come with its own limits attached. Appreciated.
Tracking a shortage from primary sources rather than rumour Replied, post #43 · Access › Shortages · 9 Jun 2026 · 0 likes Where I part company with post #42, and it is a narrow parting. Switching presentation or strength during a shortage is a prescribing decision rather than a…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #103 · Practice › Storage & stability · 9 Jun 2026 · 1 like Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. The literature is thinner on this than…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #74 · Practice › Reconstitution · 7 Jun 2026 · 0 likes Coming back to post #70, because the follow-up matters more than the original answer. A vial that will not fully dissolve: check in order: is the diluent genuinely room…
MS/MS sequence confirmation: what it costs and when it is worth it — what changed since Replied, post #35 · Analytics › Mass spectrometry · 6 Jun 2026 · 3 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2026 · 9 likes Clear enough that I do not think I have a follow-up, which is unusual.
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #58 · Practice › Storage & stability · 2 Jun 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #45 · Safety › Contraindications · 21 May 2026 · 28 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Prescription requirements and telehealth models — a second dataset Replied, post #26 · Sourcing › Regulatory · 11 May 2026 · 6 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. I have kept the units in…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #37 · Analytics › COA interpretation · 4 May 2026 · 8 likes On field-by-field walk through a certificate, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a…
The "under review" status pill and when a moderator applies it Replied, post #100 · Evidence › Preprints · 28 Apr 2026 · 5 likes Post #98 is right about the mechanism and I think understates the practical bit. Reading a preprint properly means doing some of the reviewer's job: methods first, then…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #10 · Analytics › Method validation · 24 Apr 2026 · 14 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
Anaesthesia and elective surgery: the aspiration question Replied, post #98 · Practice › Interactions · 24 Apr 2026 · 0 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer. The mechanism…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #107 · Analytics › Mass spectrometry · 23 Apr 2026 · 7 likes I read post #103 twice before replying, because I had assumed the opposite. Electrospray on a peptide of this size gives a multiply charged series rather than a single…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #103 · Practice › Storage & stability · 22 Apr 2026 · 29 likes Building on post #101 rather than restating it. What I would want before treating Storing lyophilised material long term as settled: the method, the sample, and whether…
Official shortage notices and what they authorise Replied, post #13 · Access › Shortages · 20 Apr 2026 · 0 likes Worth separating two things that post #10 runs together. A shortage of one presentation is not a shortage of all of them, and the published notices are specific about…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #29 · Evidence › Journal club · 14 Apr 2026 · 15 likes I would call the community position on SURMOUNT-4 and continuation versus withdrawal likely rather than established, and I would be comfortable defending that hedge.
A comparison of home results against a laboratory result on the same vial — does this… Replied, post #3 · Analytics › Home & field testing · 10 Apr 2026 · 30 likes Where a home observation and an independent result disagree, the independent one is measuring something more specific. That does not make the home observation useless —…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #141 · Access › Pricing · 9 Apr 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Fasting versus non-fasting and which tests care Replied, post #8 · Clinical › Bloodwork · 5 Apr 2026 · 17 likes The reason fasting versus non-fasting is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the…
Anaesthesia and elective surgery: the aspiration question Replied, post #73 · Practice › Interactions · 3 Apr 2026 · 4 likes Nothing here is medical advice and an interaction question is one where the cost of a wrong forum answer is genuinely high. Ask the prescriber or the pharmacist.
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #113 · Clinical › Bloodwork · 28 Mar 2026 · 7 likes The strongest argument against my own position on panel, stated as well as I can state it, since nobody else has yet.
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #95 · Lounge › Introductions · 17 Mar 2026 · 1 like Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #55 · Research Methods › N-of-1 designs · 16 Mar 2026 · 1 like Picking up post #52: that is the part I would want checked first. Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias.…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #74 · Start Here › How to Ask · 15 Mar 2026 · 8 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. Caveat: everything above assumes the…
[2026 update] Availability by country, dated, with primary sources Replied, post #40 · Access › International · 13 Mar 2026 · 3 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #56 · Practice › Storage & stability · 5 Mar 2026 · 0 likes Post #55 is the version of this I will quote in future. One addition. Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #127 · Compounds › Semaglutide · 23 Feb 2026 · 4 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Micro-titration: a disputed topic, argued properly — one year on Replied, post #4 · Practice › Dosing & titration · 10 Feb 2026 · 0 likes Before the thread moves on from Micro-titration — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #13 · Outcomes › Progress reports · 7 Feb 2026 · 1 like I had written a reply contradicting post #12 and deleted it. Here is what survived. Menstrual cycle: for people who menstruate, weight can shift by several pounds…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #52 · Sourcing › Regulatory · 22 Jan 2026 · 3 likes No disagreement from me. Posting only so the question does not look ignored.
Preprint servers and what screening they do Replied, post #29 · Evidence › Preprints · 19 Jan 2026 · 10 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #41 · Practice › Side effects · 16 Jan 2026 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #31 · Start Here › Welcome · 15 Jan 2026 · 17 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
A partial dose because the pen emptied mid-injection Replied, post #36 · Practice › Administration · 8 Jan 2026 · 33 likes Coming back to post #34, because the follow-up matters more than the original answer. Note the site alongside the dose. If a local reaction appears three weeks later…
Second pass at: The topic list is dense — is that deliberate? Replied, post #25 · Meta › Site feedback · 21 Dec 2025 · 22 likes Worth separating two things that post #21 runs together. Two things can be true about topic list at once: the mechanism is plausible and the evidence for the size of…
Tracking a preprint to publication: a worked example Replied, post #113 · Evidence › Preprints · 11 Dec 2025 · 6 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad.
Adolescents: a distinct evidence base — one year on Replied, post #39 · Clinical › Special populations · 1 Dec 2025 · 30 likes Where I part company with post #35, and it is a narrow parting. Nothing in this subcategory is medical advice and the questions asked here are precisely the ones that…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #34 · Documentation › Doc review · 27 Nov 2025 · 0 likes A review date is a commitment rather than a formality, and a shorter cycle for a fast-moving subject is the whole point of setting it deliberately. Worth checking…
Journal club: LEADER as the historical anchor Replied, post #7 · Evidence › Journal club · 26 Nov 2025 · 25 likes Agreed, and I will stop repeating the version of this I had been repeating.
What a purity-only report leaves out Replied, post #87 · Sourcing › Independent verification · 14 Nov 2025 · 3 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #6 · Data & Tools › Calculators · 12 Nov 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
Waist circumference technique and its repeatability Replied, post #15 · Outcomes › Progress reports · 11 Nov 2025 · 7 likes Adding the measurement that post #12 says would settle it. The strongest argument against my own position on waist circumference technique, stated as well as I can…
Where the integrator drew the baseline, and how much it moved the number Replied, post #17 · Analytics › HPLC & UHPLC · 1 Nov 2025 · 2 likes Adding the measurement that post #16 says would settle it. A relative retention time against a known peak travels much better than an absolute one, and almost nobody…
EMA product information as a primary source Replied, post #20 · Regional › European Union · 1 Nov 2025 · 1 like Picking up post #17: that is the part I would want checked first. An observation about EMA product information that I cannot explain and am posting anyway, on the…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #131 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Documentation that appears only after payment Replied, post #28 · Sourcing › Red flags · 19 Sep 2025 · 0 likes Post #25 answers the question as asked. The question underneath it is different. The guidelines draw that line for a practical reason as much as a fair one: reports…
Hypertension improvement and when medication needs revisiting Replied, post #63 · Clinical › Comorbidities · 16 Sep 2025 · 17 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them. I have seen it go both ways, which is…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #104 · Evidence › Study critique · 16 Sep 2025 · 28 likes Where I part company with post #102, and it is a narrow parting. The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a…
Payment method and the leverage it gives you, ranked Replied, post #12 · Sourcing › Payments · 14 Sep 2025 · 24 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Currency conversion: payment in your local currency often involves…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #19 · Evidence › Study critique · 12 Sep 2025 · 21 likes Where I would push back on the Reverse causation consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Thyroid function tests during substantial weight change Replied, post #50 · Clinical › Bloodwork · 3 Sep 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #25 · Analytics › Method validation · 1 Sep 2025 · 2 likes A note on scope: what I am saying about LOD and LOQ applies to the case in the first post and I would not extend it further without checking.
Coming back to: Why quantitation is the hard part, not detection Replied, post #57 · Analytics › Home & field testing · 28 Aug 2025 · 24 likes I read post #53 twice before replying, because I had assumed the opposite. Having read the whole quantitation thread before replying: the question in the first post has…
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #55 · Practice › Side effects · 26 Aug 2025 · 0 likes Practical answer on Fatigue, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
Which panel is worth repeating and which is worth ignoring Replied, post #88 · Clinical › Bloodwork · 18 Aug 2025 · 17 likes If someone has run panel properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #34 · Analytics › HPLC & UHPLC · 17 Aug 2025 · 9 likes Following this. I have the same question and no better information than the first post.
Distinguishing a deletion sequence by mass alone — the long version Replied, post #41 · Analytics › Mass spectrometry · 16 Aug 2025 · 0 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
Follow-up: Why appetite effects are mostly central Replied, post #15 · Pharmacology › Receptor biology · 10 Aug 2025 · 0 likes Worth separating two things that post #11 runs together. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite)…
Are there stupid questions here? A staff answer, at length Replied, post #58 · Start Here › Welcome · 10 Aug 2025 · 9 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Coming back to: When "no data" is the complete and final answer Replied, post #77 · Compounds › Other compounds · 9 Aug 2025 · 15 likes Post #76 is the version of this I will quote in future. One addition. The honest summary for most of this subcategory: a plausible mechanism, animal data, and…
Travel coolers and how long they really hold Replied, post #53 · Devices › Cold chain · 5 Aug 2025 · 2 likes I had written a reply contradicting post #51 and deleted it. Here is what survived. What I can speak to on travel coolers is narrow, so I will keep it narrow rather…
Coming back to: Cross-border purchase rules within the EU Replied, post #14 · Regional › European Union · 28 Jul 2025 · 3 likes Everything in post #12 holds. The case it does not cover is the one I have. Anyone quoting an eligibility threshold should cite the national document, because…
Titles that describe the question, not the situation Replied, post #56 · Start Here › How to Ask · 25 Jul 2025 · 0 likes On post #54 — agreed on the reasoning, with one qualification. A question about somebody else's post should be a reply to that post, not a new topic. A question the…
Antibiotics and a course of something with delayed emptying Replied, post #97 · Practice › Interactions · 22 Jul 2025 · 33 likes Narrowing post #96, because the general version has more than one answer. On antibiotics: the maintained page in the documentation commons covers the general case with…
A field-by-field walk through a certificate of analysis Replied, post #103 · Analytics › COA interpretation · 17 Jul 2025 · 22 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes.
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 8 likes The reason Nausea profile of amylin analogues is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #58 · Compounds › Oral incretins · 4 Jul 2025 · 0 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #24 · Analytics › Method validation · 26 Jun 2025 · 8 likes Adding a data point of agreement rather than a data point.
An emergency department visit, described afterwards Replied, post #32 · Safety › Adverse events · 18 Jun 2025 · 1 like Reporting here and reporting to a national scheme are not alternatives. The second is what feeds safety surveillance.
Journal club: SURMOUNT-1, read without the press release Replied, post #137 · Evidence › Journal club · 14 Jun 2025 · 12 likes Post #135 describes the usual case. This is about the unusual one. On SURMOUNT-1, I would rather understate and be corrected upward than overstate and be quoted. That…
Titles that describe the question, not the situation Replied, post #27 · Start Here › How to Ask · 12 Jun 2025 · 0 likes Post #23 put the caveat in the right place and I want to underline it. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #133 · Practice › Reconstitution · 12 Jun 2025 · 2 likes Swirling until fully clear before drawing is worth the extra minute. A partially dissolved preparation is not uniform and the first dose out of it is not the same as…
Reading an MS report that only gives you a single number Replied, post #96 · Analytics › Mass spectrometry · 2 Jun 2025 · 13 likes Calibration state at the time of the run determines whether the ppm figure means anything. A report that states when the instrument was last calibrated is unusual and…
A supplier that answers analytical questions with restated claims Replied, post #88 · Sourcing › Red flags · 1 Jun 2025 · 0 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #28 · Compounds › Repair & healing peptides · 1 Jun 2025 · 0 likes Adding the measurement that post #25 says would settle it. Where the TB-500 and thymosin beta-4 reasoning breaks down for me is the step from the group result to the…
Antibiotics and a course of something with delayed emptying Replied, post #53 · Practice › Interactions · 30 May 2025 · 0 likes Narrowing post #52, because the general version has more than one answer. A pharmacist can answer most questions in this subcategory in a few minutes with access to a…
Validating a calculator against hand arithmetic — what changed since Replied, post #96 · Data & Tools › Calculators · 28 May 2025 · 3 likes This follows post #93 rather than contradicting it. Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input…
Pregnancy as an absolute contraindication Replied, post #104 · Safety › Contraindications · 21 May 2025 · 1 like The most common error here is treating a trial exclusion criterion as a contraindication. They are different documents with different purposes. The claim is narrower…
Publishing an inconvenient result: a case study Replied, post #20 · Sourcing › Independent verification · 15 May 2025 · 33 likes Publishing an inconvenient result is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
Requesting a translation of an existing page Replied, post #17 · Documentation › Wiki requests · 14 May 2025 · 5 likes Where a request is for a translation or a regional version, the maintenance burden doubles and the proposal should say who carries it. That is all I can say without…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #45 · Sourcing › Independent verification · 4 May 2025 · 32 likes Helpful, and easy to find again, which is half of what a good reply is.
A well-designed study with a badly written abstract Replied, post #54 · Evidence › Study critique · 1 May 2025 · 0 likes What I want from this well-designed study thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Titles that describe the question, not the situation Replied, post #2 · Start Here › How to Ask · 24 Apr 2025 · 10 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
A report I filed that turned out to be wrong, and the correction Replied, post #23 · Sourcing › Vendor reports · 22 Apr 2025 · 4 likes Coming back to post #22, because the follow-up matters more than the original answer. Where you have no independent result, a documentation report is still worth…
Payment mechanics and the recovery options that do not exist — what changed since Replied, post #5 · marked as the solution · Sourcing › Payments · 19 Apr 2025 · 7 likes Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
Follow-up: Documentation that appears only after payment Replied, post #3 · Sourcing › Red flags · 16 Apr 2025 · 15 likes Picking up the opening post: that is the part I would want checked first. What I would tell a new member reading about Documentation for the first time: the confident…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #35 · Compounds › Tirzepatide · 5 Apr 2025 · 0 likes The practical version of GIP component of tirzepatide is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
Adjudicated events and why the definition matters — the long version Replied, post #77 · Evidence › Trials · 2 Apr 2025 · 6 likes Taking post #75 at face value and following it one step further. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method…
Coming back to: Oxidation pathways for methionine and tryptophan Replied, post #5 · Analytics › Impurities & related substances · 24 Mar 2025 · 28 likes Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged material it is the modification that grows. If anyone can point at…
Aggregated purity results across four services, with caveats Started this topic · Data & Tools › Datasets · 21 Mar 2025 · 39 likes Posting this under the heading it deserves: Aggregated purity results across four services, with caveats Everything below is what sits behind that. Aggregated purity…
Coming back to: An 18-month record including the parts that went badly Replied, post #29 · Outcomes › Progress reports · 19 Mar 2025 · 4 likes Practical answer on 18-month record, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #40 · Compounds › Tirzepatide · 16 Mar 2025 · 0 likes Post #36 and I disagree about the size of the effect, not about the direction. Research-use-only tirzepatide is not approved for human use and is not made to…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #129 · Compounds › Semaglutide · 15 Mar 2025 · 16 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #155 · Sourcing › Regulatory · 6 Mar 2025 · 13 likes Small methodological point on pharmaceutical compounding rules: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #142 · Sourcing › Regulatory · 5 Mar 2025 · 29 likes Second this, and I would have said it less carefully.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #115 · Sourcing › Regulatory · 4 Mar 2025 · 0 likes Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. Take the reasoning and check the…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #23 · Evidence › Meta-analyses · 29 Jan 2025 · 4 likes Fair, and the limits you put on it are the part I will remember.
What we do not know about retatrutide, listed explicitly Replied, post #74 · Compounds › Retatrutide · 29 Jan 2025 · 5 likes Coming back to post #72, because the follow-up matters more than the original answer. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a…
Fibre intake when total intake falls, and the constipation link Replied, post #19 · Nutrition & Training › Protein & intake · 20 Jan 2025 · 6 likes Taking post #16 at face value and following it one step further. An update on my earlier fibre intake post: the pattern held for another six weeks and then stopped,…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #67 · Compounds › Other compounds · 18 Jan 2025 · 17 likes I had written a reply contradicting post #63 and deleted it. Here is what survived. The confident answers on Research-use-only status and the well-sourced answers are…
UK access routes, dated and sourced — a second dataset Replied, post #28 · Regional › UK & Ireland · 18 Jan 2025 · 4 likes Helpful, and easy to find again, which is half of what a good reply is.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #30 · Compounds › Semaglutide · 17 Jan 2025 · 3 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #21 · Pharmacology › Receptor biology · 8 Jan 2025 · 1 like Answering the question post #19 raises rather than the one it answers. Bias and desensitisation: receptors can be biased (preferentially activating some downstream…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #8 · Compounds › Semaglutide · 25 Dec 2024 · 0 likes The reason published dose-response for semaglutide is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting…
Building a sensible monitoring schedule with your prescriber Replied, post #26 · Clinical › Bloodwork · 19 Dec 2024 · 16 likes Reading rather than answering, but this is the post I would point somebody at.
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #23 · Data & Tools › Calculators · 18 Dec 2024 · 0 likes I read post #19 twice before replying, because I had assumed the opposite. Titration planning: a calculator that shows you the escalation schedule for different…
Two sessions a week versus four: what the evidence supports Replied, post #31 · Nutrition & Training › Resistance training · 11 Dec 2024 · 21 likes That is consistent with mine, for whatever one more account is worth.
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #43 · Sourcing › Regulatory · 1 Dec 2024 · 7 likes Post #41 and I disagree about the size of the effect, not about the direction. Off-label use and medical practice: clinicians can prescribe approved medications…
Washout with a one-week half-life: the arithmetic Replied, post #36 · Research Methods › N-of-1 designs · 29 Nov 2024 · 0 likes Everything in post #33 holds. The case it does not cover is the one I have. The failure mode on washout is boring rather than dramatic. It is almost always the step…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #44 · Clinical › Special populations · 23 Nov 2024 · 25 likes Where the Type 1 diabetes reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #8 · Clinical › Special populations · 19 Nov 2024 · 22 likes Building on post #7 rather than restating it. A note on how Type 1 diabetes gets discussed rather than on Type 1 diabetes itself: the confident posts get the replies…
Revisiting: Moderation log format change Replied, post #24 · Meta › Announcements · 11 Nov 2024 · 0 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. The confident answers on Moderation log format change and the…
Time to steady state after a dose increase Replied, post #89 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 21 likes Taking post #86 at face value and following it one step further. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody…
Buffers, pH and why a formulation is a formulation Replied, post #15 · Pharmacology › Formulation chemistry · 30 Oct 2024 · 0 likes Buffers and pH: the pH of a solution is buffered to maintain stability. The buffer system (phosphate, Tris, or other) is chosen to keep the solution at the pH where the…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #126 · Clinical › Comorbidities · 29 Oct 2024 · 0 likes Nothing here is medical advice and clinicians posting in this subcategory say so on their own account rather than because a rule requires it.
Irish differences from the UK position Replied, post #56 · Regional › UK & Ireland · 24 Oct 2024 · 7 likes Irish differences is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
Requesting a page: what makes a good request — what changed since Replied, post #123 · Documentation › Wiki requests · 13 Oct 2024 · 5 likes If a request is declined, the reasoning is written down, and it is worth reading because it usually describes a better version of the same idea. I would want a second…
Why I ask for the gradient before I discuss the number Replied, post #22 · Analytics › HPLC & UHPLC · 22 Sep 2024 · 4 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
Pen wastage and its effect on real cost Replied, post #22 · Access › Pricing · 5 Sep 2024 · 3 likes Independent testing is a real cost and belongs in the comparison. A cheaper supplier tested every lot may cost more in total.
Progressive overload when the scale is falling — one year on Replied, post #16 · Nutrition & Training › Resistance training · 31 Aug 2024 · 10 likes I read post #12 twice before replying, because I had assumed the opposite. The version of Progressive overload that I was taught turned out to be a teaching…
Reading a meta-analysis you disagree with, fairly Replied, post #10 · Evidence › Meta-analyses · 11 Aug 2024 · 0 likes On reading a meta-analysis the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #39 · Practice › Dosing & titration · 4 Aug 2024 · 14 likes Adding the measurement that post #36 says would settle it. The version of four-week escalation interval that circulates here is a simplification of a simplification. It…
Reporting a discrepancy without making an allegation Replied, post #12 · Sourcing › Vendor reports · 2 Aug 2024 · 2 likes Offering a way to settle reporting a discrepancy rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
The mass-error checker and its intended scope Replied, post #143 · Data & Tools › Calculators · 22 Jul 2024 · 17 likes Post #140 is right about the mechanism and I think understates the practical bit. Mass error checking: enter your observed mass and theoretical mass and check whether…
Naming conventions for research peptides and the confusion they cause — one year on Started this topic · Compounds › Other compounds · 3 Jul 2024 · 7 likes Naming conventions for research peptides and the confusion they cause — one year on — setting out what I have, and where I think it stops being reliable. Asking about…
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #12 · Nutrition & Training › Resistance training · 17 Jun 2024 · 29 likes That matches what I have seen, for whatever a single anecdote is worth.